Ocular Therapeutix (OCUL)
(Delayed Data from NSDQ)
$8.59 USD
+0.13 (1.54%)
Updated Sep 24, 2024 04:00 PM ET
After-Market: $8.58 -0.01 (-0.12%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/5/24 |
---|---|
Current Quarter | -0.23 |
EPS Last Quarter | -0.24 |
Last EPS Surprise | -9.09% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.16 |
Next Year | -0.97 |
EPS (TTM) | -1.27 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 17.68M | 18.36M | 67.40M | 75.48M |
# of Estimates | 4 | 4 | 4 | 4 |
High Estimate | 19.00M | 21.40M | 72.20M | 85.20M |
Low Estimate | 16.82M | 17.07M | 65.10M | 71.70M |
Year ago Sales | 15.08M | 14.80M | 58.44M | 67.40M |
Year over Year Growth Est. | 17.24% | 24.05% | 15.32% | 12.00% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.23 | -5.68 | -1.16 | -0.97 |
# of Estimates | 6 | 4 | 4 | 6 |
Most Recent Consensus | -0.21 | -0.20 | -1.12 | -0.82 |
High Estimate | -0.21 | -0.20 | -1.12 | -0.82 |
Low Estimate | -0.30 | -22.00 | -1.20 | -1.19 |
Year ago EPS | -0.51 | -0.28 | -1.02 | -1.16 |
Year over Year Growth Est. | 54.90% | -1,928.57% | -13.73% | 16.74% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 2 | 2 | 2 | 3 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 2 | 2 | 2 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.23 | -5.68 | -1.16 | -0.97 |
7 Days Ago | -0.23 | -5.68 | -1.16 | -0.97 |
30 Days Ago | -0.23 | -5.68 | -1.16 | -0.97 |
60 Days Ago | -0.21 | -0.25 | -1.14 | -0.94 |
90 Days Ago | -0.21 | -0.25 | -1.14 | -0.94 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.23 | -5.68 | -1.16 | -0.97 |
Zacks Consensus Estimate | -0.23 | -5.68 | -1.16 | -0.97 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.24 | -0.24 | -0.28 | -0.51 | NA |
Estimate | -0.22 | -0.18 | -0.28 | -0.27 | NA |
Difference | -0.02 | -0.06 | 0.00 | -0.24 | -0.08 |
Surprise | -9.09% | -33.33% | 0.00% | -88.89% | -32.83% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more